## **Core Concept**
Alzheimer's disease is a progressive neurodegenerative disorder characterized by cognitive decline and memory loss. It involves various pathological changes in the brain, including amyloid-beta plaque deposition, neurofibrillary tangle formation, and neuronal loss. The nucleus **basalis of Meynert** is notably affected in Alzheimer's disease.

## **Why the Correct Answer is Right**
The **nucleus basalis of Meynert**, also known as the **substantia innominata**, is a collection of nerve cells in the **basal forebrain** that provides the major cholinergic input to the **cerebral cortex**. This nucleus plays a critical role in cognitive functions, particularly in attention and memory. In Alzheimer's disease, the nucleus basalis of Meynert undergoes significant neuronal loss, leading to a decrease in cholinergic neurotransmission, which contributes to the cognitive impairments observed in the disease.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not specify a known structure related to Alzheimer's disease pathology.
- **Option B:** This option is incorrect as it does not directly relate to the primary pathological changes or specific nuclei known to be involved in Alzheimer's disease.
- **Option D:** This option is incorrect because it does not accurately represent a nucleus primarily implicated in the pathophysiology of Alzheimer's disease.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the **nucleus basalis of Meynert** is the site of significant neuronal loss in Alzheimer's disease, contributing to the cholinergic hypothesis of the disease. This hypothesis suggests that the degeneration of cholinergic neurons in the basal forebrain, including the nucleus basalis of Meynert, leads to the cognitive decline seen in Alzheimer's.

## **Correct Answer:** C. Nucleus basalis of Meynert.